Surgalign announced the milestone 100th case with its Cortera™ posterior spinal fixation system.
Surgalign received FDA 510(k) clearance in August 2022, and Cortera and was introduced in a limited market release shortly thereafter. During this initial market release, Surgalign’s goal has been to collect clinical and design feedback on the system from a range of spine surgeons. Efforts are now underway to secure additional products, and the company intends to ramp up commercialization in the first half of 2023.
Cortera is a 5.5/6.0mm rod pedicle screw system that has both open and MIS modules. Surgalign intends to develop additional implants and instruments to add to the Cortera System over the next three to four years and is also working to integrate Cortera with its HOLO Portal™ surgical guidance system.
Terry Rich, President and Chief Executive Officer of Surgalign, said, “Cortera represents the first organically developed product at Surgalign and we believe holds great promise for our company and our customers. Market reception has been very strong to date and we look forward to moving into the next phase of our commercial launch in 2023, while continuing to drive innovation in the system.”
Surgalign announced the milestone 100th case with its Cortera™ posterior spinal fixation system.
Surgalign received FDA 510(k) clearance in August 2022, and Cortera and was introduced in a limited market release shortly thereafter. During this initial market release, Surgalign’s goal has been to collect clinical and design feedback on the...
Surgalign announced the milestone 100th case with its Cortera™ posterior spinal fixation system.
Surgalign received FDA 510(k) clearance in August 2022, and Cortera and was introduced in a limited market release shortly thereafter. During this initial market release, Surgalign’s goal has been to collect clinical and design feedback on the system from a range of spine surgeons. Efforts are now underway to secure additional products, and the company intends to ramp up commercialization in the first half of 2023.
Cortera is a 5.5/6.0mm rod pedicle screw system that has both open and MIS modules. Surgalign intends to develop additional implants and instruments to add to the Cortera System over the next three to four years and is also working to integrate Cortera with its HOLO Portal™ surgical guidance system.
Terry Rich, President and Chief Executive Officer of Surgalign, said, “Cortera represents the first organically developed product at Surgalign and we believe holds great promise for our company and our customers. Market reception has been very strong to date and we look forward to moving into the next phase of our commercial launch in 2023, while continuing to drive innovation in the system.”
Copy to clipboard 
